Background. We conducted a large national cohort study to examine the risk of cancer among men and women with genital warts (GW).
Genital warts (GW) are common in both men and women [1] . They are generally regarded as a benign condition not associated with mortality, but they can be difficult to treat, and recurrence is often seen. GW are caused by infection with human papillomavirus (HPV), most often the nononcogenic types 6 and 11 [2] . However, coexistence of other HPV-types, both nononcogenic and oncogenic, is frequent [3, 4] . The oncogenic certain HPV types are associated with cancers in anogenital sites (ie, cervix, vulva, vagina, anus, and penis) and head and neck sites. Whether HPV is associated with cancer at other sites and organs has not been established, but it has been suggested that HPV infection could be playing a role in the development of nonmelanoma skin cancer, breast cancer, and colon cancer [5] [6] [7] . The hypothesis is that individuals with GW may have an increased risk of developing HPVassociated cancer due to an increased likelihood of also harboring oncogenic HPV types [8, 9] .
Several case-control studies have shown an association between a history of GW and anogenital cancer [9] [10] [11] [12] [13] [14] . However, these studies are generally limited by a small sample size, and some involved the study of only one cancer site. To date, three cohort studies, 2 in Sweden (with 3260 and 10,971 individuals) and 1 in Denmark (9522 individuals), have examined the association between GW and cancer [8, 15, 16] . In the first Swedish study, no significant correlation between GW and cancer was observed in women, but men with GW had an increased risk of genitourinary cancer [16] . The Danish study included only women and found markedly increased risks of anogenital and smokingrelated cancers [15] . The second Swedish study reported significantly elevated risks of anogenital cancer and nonmelanoma skin cancer in both sexes [8] . No cohort study has investigated the risk specifically of HPV-associated head and neck cancers after GW.
The aim of this nationwide study was to compare the incidence of cancer among men and women from Denmark who received a diagnosis of GW during a 31-year period with that of the general population. To pursue this, we extended the previous Danish cohort study by 17 years and expanded the study to include both sexes.
METHODS AND MATERIAL

Study Population
The study cohort of patients with GW was identified from the Danish National Patient Register [17] , which has recorded all nonpsychiatric hospitalizations in Denmark since 1977 and all outpatient visits since 1995. In Denmark, a 10-digit personal identification number has been assigned by the Danish Civil Registration System to all Danish citizens since 1968 [18] . The personal identification numbers, which contain information on sex and date of birth, allow accurate linkage between population-based registries. Diagnoses were coded according to the International Classification of Diseases, Eighth Revision (ICD-8), in 1978-1993 and, thereafter, according to the International Classification of Diseases, Tenth Revision (ICD-10). The records of GW were selected using the following codes: 099.90 for ICD-8 and A63.0 for ICD-10.
We identified a total of 16,525 men and 33,422 women with a diagnosis of GW in the patient register during the period from 1 January 1978 through 31 December 2008. Individuals with several records of GW were included only once, at the time of the first diagnosis of GW.
Follow-up
We used the personal identification number to link the cohort to the Danish Civil Registration System to obtain information on migration and death. Cancer occurrence in the study cohort was ascertained by linkage to the Danish Cancer Registry, which has recorded cancer occurrence nationwide in Denmark since 1943. The cancer registry has been shown to have accurate and almost complete ascertainment of cancer cases [19, 20] . Only primary cancer cases were identified. The patients were followed from 1 month following the GW diagnosis until death, emigration, or 31 December 2009, whichever came first.
We excluded 34 men and 54 women whose personal identification number was invalid or who were not Danish citizens and 61 men and 31 women who had emigrated or died during the first month following the GW diagnosis. Since there is some association between the different anogenital cancers and since GW can become clinically detectable as a result of cancer treatment, 275 men and 404 women with a previous cancer diagnosis or a cancer diagnosis in the same month as the first diagnosis of GW were also excluded. The remaining 16,155 men and 32,933 women constituted our final study cohort.
On the basis of the present literature, we classified head and neck cancers of squamous cell origin (International Classification of Diseases for Oncology [ICD-O] morphology codes 8050-8084 and 8120-8131) into 3 groups of supposedly decreasing HPV-association: HPV-associated cancers (ICD-O topography codes C01.9, C02.4, C02.8, C09, C10.2, C10.8, C10.9, C11.1, C14.0, C14.2, and C14.8), potentially HPVassociated cancers (C02.0-C02.3, C02.9, C03-C06, C10.0, C10.1, C10.3, C14.1, and C32), and HPV-unrelated head and neck cancers (C00, C07, C08, C10.4, C11.0, C11.2-C11.9, C12, C13, C30, and C31). We further created 2 major groups of cancer, using ICD-O topography codes: a HPV-related group comprising cancer of anus (C21), vulva (C51), vagina (C52), uterine cervix (C53), and penis (C60) and HPV-associated head and neck cancers and a smoking-related group comprising cancers of the buccal cavity and pharynx (C00-C14, C46.2), esophagus (C15), stomach (C16), liver (C22), pancreas (C25), larynx (C32), lung (C33, C34, C39), uterine cervix (C53), kidney (C64), and urinary bladder (C67) and myeloid leukemia (C92).
Statistical Analyses
The number of cancer cases observed among patients with GW was compared with that expected in the general Danish population. The expected number was estimated by multiplying the number of person-years of the cohort members with the sex-specific cancer rates according to 5-year age groups and 5-year calendar periods. Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) were computed as estimates of relative risks, assuming a Poisson distribution of the outcomes [21] . SIRs for cancer were secondly stratified according to follow-up time (<1 year, 1-4 years, 5-9 years, and ≥10 years) and for selected sites according to age (<20 years, 20-29 years, 30-39 years, and ≥40 years) and year of GW diagnosis (1978-1989, 1990-1999, and 2000-2004) . All analyses were computed using SAS software (version 9.1), and the study was approved by the Danish Data Protection Agency.
RESULTS
Overall Risk of Cancer
A total of 49,088 patients (33% men and 67% women) who received a diagnosis of GW were enrolled in the study. The mean follow-up time was 12 years for men and 13 years for women, and more than half of the study population was followed for ≥10 years (54% of men and 57% of women). With a median age of 23 years, women generally acquired GW somewhat earlier than men (median age, 27 years). Overall, we observed 2363 cancers, with 1806.6 cancers expected in the general population, yielding a SIR of 1.3 (95% CI, 1.3-1.4), with the risk being significantly higher in men (SIR, 1.5; 95% CI, 1.4-1.6) than in women (SIR, 1.2, 95% CI, 1.2-1.3) ( Table 1 ). This elevated risk of cancer was due partly to an increased SIR at HPV-related sites, for which men again experienced a significantly higher risk than women (SIR for men, 7.2 [95% CI, 5.5-9.2]; SIR for women, 2.8 [95% CI, 2.4-3.1]).
The highest risk estimate was found for anal cancer in men. On the basis of 29 anal cancers, men with former GW had a SIR of 21.5 (95% CI, 14.4-30.9). A markedly increased risk was also observed for penile cancer (SIR, 8.2; 95% CI, 4.1-14.6). In women the SIR for anogenital sites was highest for vulva cancer (SIR, 14.8; 95% CI, 11.7-18.6) followed by anal cancer (SIR, 7.8; 95% CI, 5.4-11.0). Although based on much fewer cases (n = 6), the risk of vaginal cancer was also significantly elevated among women with a history of GW (SIR, 5.9; 95% CI, 2.2-12.9). Finally, we observed an increased risk of cervical cancer (SIR, 1.5; 95% CI, 1.3-1.8).
When examining head and neck cancers according to anatomical site, especially tonsillar cancer had high SIRs (SIR for men, 4.6 [95% CI, 2.7-7.2]; SIR for women, 4.7 [95% CI, 2.3-8.4]). In addition, the risks of cancers of the mouth, pharynx, and larynx were significantly increased in both sexes combined. Stratification of the head and neck cancers according to their association with HPV yielded a clear pattern: in both sexes the risk was clearly highest for HPV-associated cancers, followed by potentially HPV-associated cancer, and the lowest risk or no risk increase was found in HPV-unrelated head and neck cancers (Table 1) .
For nonmelanoma skin cancer, a pattern appeared toward increased risk after a diagnosis of GW, with SIRs being moderately increased (SIR of basal cell carcinoma for men, (Table 1) . Conversely, the risk at almost all the remaining cancer sites did not differ significantly from that expected in the general population. Only Hodgkin and non-Hodgkin lymphoma were above expectation, especially non-Hodgkin lymphoma among men (SIR, 3.0; 95% CI, 2.3-4.0) ( Table 1) .
Genital Sites of Cancer, According to Length of Follow-up
For anal and vulvar cancer, the SIRs were highest within the first year of follow-up, and although the risk declined during the consecutive follow-up periods, the SIRs stayed significantly increased ≥10 years following GW diagnosis (Table 2) . A similar but not so consistent trend was seen for penile cancer, for which the majority of cases were diagnosed within the first year of follow-up. However, the risk estimate was also elevated, albeit nonsignificantly, ≥10 years after GW diagnosis (SIR, 3.8; 95% CI, 0.8-11.0) ( Table 2 ). The SIR for cervical cancer remained constantly increased during follow-up and was significant 5-9 years and ≥10 years after GW diagnosis ( Table 2) . 
Nongenital Sites of Cancer, According to Length of Follow-up
The increased risk of tonsillar cancer did-unlike the other cancer sites in Tables 2 and 3 -not become apparent until 5 years after the GW diagnosis, but it then stayed elevated throughout the follow-up period in both men and women (Table 3) . Squamous cell carcinomas of the skin were in excess primarily within the first year, while the SIRs of basal cell carcinomas did not vary greatly with length of follow-up and remained significantly elevated after >10 years following GW in both sexes combined (Table 3) . No clear trends were found for Hodgkin and non-Hodgkin lymphoma according to followup time, and no trends at all were observed for breast and colon cancer (Table 3) .
Trends According to Year and Age of GW Diagnosis
Finally, we examined SIR estimates according to length of follow-up, stratified by age at GW diagnosis and year of the GW diagnosis, for smoking-related and HPV-associated cancers (Table 4) . No apparent trends related to age and calendar year at GW diagnosis were seen for smoking-related cancers, whereas the SIR estimates for HPV-associated cancers increased with increasing age and year of GW diagnosis, especially among men.
DISCUSSION
In this large cohort study, we found significantly increased risks of anogenital cancer and certain head and neck cancers in individuals who received a diagnosis of GW. For most HPV-related cancers, a sustained excess risk was evident even 10 years after the GW diagnosis. We also observed increased risks of smoking-related cancers, nonmelanoma skin cancer, and Hodgkin and non-Hodgkin lymphoma, although these findings were based on lower risk estimates. The reason why individuals with GW have a subsequently increased risk of cancer is not known, but several hypotheses can potentially explain our observations. High-risk HPV types are often found in GW [4, 22] , which may in itself predispose to cancer. However, HPV infection is often transient and without symptoms, and only some infected individuals develop GW. This selection could potentially be caused by immunological differences between individuals, which in theory could predispose some to a higher tendency toward persistence of the HPV infection and, thereby, to an increased risk of cancer. Behavioral confounding may also explain part of the excess cancer risk observed among patients with GW. Apart from higher sexual activity (eg, a higher number of partners), individuals with a GW diagnosis may on average have a higher consumption of alcohol or smoking or other deleterious lifestyle habits. Our risk estimates for smoking-related cancers support this assumption, although there is some overlap between smoking-related and HPV-associated cancers.
Male homosexual behavior has been shown to increase the risk of both GW and anal cancer [10, 23] . The observation of higher risks of HPV-related cancers among men than among women may be confounded by male homosexual behavior. This possibility is supported by the sex-specific period prevalences of HIV infection in the cohort (1.0% among men vs 0.2% among women). The apparent higher risk of HPV-related cancers among men may be further mediated through differences in screening, since anal cancer, for which there is no screening, is driving the rates in men, whereas cervical cancer, for which there is an efficient nationwide screening program, is lowering the rates in women.
Another possibility is that cancer development may be related to a local immune suppression or to the inflammatory process itself [24] [25] [26] . We observed the highest risk estimates of cancer in the same anatomical sites at which GW are predominately located (anal, vulvar, and penile sites) [27] , which could suggest that cancers tend to arise near the site of previous GW, although subclinical infection may exist in a wider area. Finally, there are examples of direct malignant transformation of GW [28] [29] [30] , but this observation does not seem to explain the long term (≥10 years) elevated risk of cancer.
The strong association between GW and anal, vulvar, and penile cancer is in accordance with previous studies, some of which have been able to adjust for number of sex partners, education level, and smoking history [8, 10-12, 14, 23, 31-36] . The rarity of vaginal cancer limits our ability to address risk factors for this cancer. In a case-control study, Daling et al. [37] failed to see a significant association between GW and vaginal cancer. However, this was based only on 37 cases, and since vaginal GW are not directly visible to the patient, selfreported GW may be underestimated in case-control studies.
In line with other case-control studies and 1 cohort study, we found GW to be a risk factor for vaginal cancer [8, 13, 33] . Although tobacco and alcohol remain the major risk factors for head and neck cancer, recent research suggests that HPV may also be responsible for a large proportion of some of these cancers, especially tonsillar and base of tongue cancers [38] . In a case-control study adjusting for smoking and alcohol, Schwartz et al. [39] found that a history of GW was a significant risk factor for oral cancer in men. We found this association in both men and women. Nordenvall et al. [8] provided 1 risk estimate for nearly all head and neck sites combined and observed a >3-fold elevated risk. When head and neck cancers were grouped according to their relation to HPV, the risk following a GW diagnosis was confined to the HPVassociated and potentially HPV-associated sites, and no significant excess risk was observed for the sites potentially not related to HPV. This strongly supports the hypothesis that HPV plays a key role in the pathogenesis of cancer at a considerable proportion of head and neck sites.
Our findings of increased risk of nonmelanoma skin cancer after GW are in line with results from some previous studies that examined the association between nonmelanoma skin cancer and HPV [7, 40] . However, this potential HPV association is still controversial [41] . Cutaneous HPV types (which are the most frequent HPV types identified in nonmelanoma skin cancers) have primarily been found on sun-exposed areas, and it has been suggested that HPV may be a cofactor in the oncogenesis of nonmelanoma skin cancer, together with factors like genotoxic ultraviolet light and immunosuppression [40] . In addition, some reports have indicated that smoking may also be a potential risk factor for squamous cell carcinoma of the skin [42] . This could be due to the direct effects of tobacco or to a greater likelihood among smokers to acquire HPV infection of the skin. A more recent and larger study among men did not confirm this association [43] , but the uncertainty regarding the significance of this risk factor complicates the interpretation of our results. More research on this issue is needed.
HPV has been detected in cancers at several anatomical sites, and the degree to which these cancers may be HPV associated is still debated. A recent review that evaluated a possible relation between HPV and colorectal cancer reported a significantly higher overall HPV detection rate in tumor tissue than in diseasefree controls. However, many of the reviewed studies had important methodological limitations [5] . Similarly, a recent meta-analysis reported a significantly increased risk of breast cancer with HPV positivity (OR, 3.6; 95% CI, 1.4-9.3) [6] . In contrast to these findings, our results do not support an association between HPV and breast or colorectal cancer.
In the present study, increased risks of Hodgkin lymphoma in both sexes and non-Hodgkin lymphoma in men were found. Although these associations may have occurred by chance, it is noteworthy that Nordenvall et al. [8] observed similar results. These authors suggested underlying immunodeficiency as an explanation on that basis of a study of organ transplant recipients who had an increased risk of cancer at the same sites as seen in our study (including anogenital cancer, nonmelanoma skin cancer, non-Hodgkin lymphoma, and cancer of oral cavity, esophagus, lung, and bladder) [44] . This hypothesis is thus compatible with our results.
The vast majority of excess penile cancers were seen within the first year of follow-up. This could potentially be attributable to misdiagnosis of the early stages of cancer as GW (diagnostic bias), or earlier cancer detection caused by treatment of GW in the same area (surveillance bias). However, other studies have reported increased rates of penile cancer, also >1 year after GW [12, [34] [35] [36] , supporting that the observed risk of penile cancer is real. The irregular risk pattern according to length of follow-up found in this study could also be attributed to the small number of penile cancer cases. For the other cancer sites with overall increased risks, the excess risk was still present beyond the first year of follow-up.
The most striking result drawn from our final stratification by age at GW diagnosis and calendar year of GW diagnosis was an increased risk of HPV-associated cancers with older age at GW diagnosis. Possibly, this increased risk of cancer according to age may be mediated through a relatively decreased immunity in older ages.
Our study has several strengths: the large study population, which is >4-fold larger than anyof the previous cohort studies, provided sufficient statistical power to evaluate the risk of rare cancers. In addition, the combination of a large cohort and a long followup time also allowed us to make accurate estimations of the long term (≥10 years) risk of cancer following a GW diagnosis. Finally, the cohort was well-defined, and the results are reliable owing to the accuracy of the hospital and cancer registers [17, 19] .
The study also has limitations. We included all patients who received a diagnosis at hospitals, but GW are often diagnosed outside of the hospital, by general practitioners, dermatologists, or gynecologists who do not report to the Danish National Patient Register. Individuals treated at the hospitals could have more severe and persistent disease, and we may therefore overestimate the general risk of subsequent cancer. On the other hand, underestimation of the risk is also a possibility because many of the cohort members did not reach the age at which most cancers appear (8% reached 60 years of age). Another limitation is the lack of information on sexual behavior, socioeconomic status, and smoking history, as these factors likely differ in the cohort and the general population. For example, the increased incidence of smokingrelated cancers suggests a greater proportion of smokers in our cohort.
In conclusion, our findings indicate that patients with GW belong to a high-risk group in regard to subsequent HPV-related cancer. The results add to the evidence of a link between HPV and anogenital cancer, head and neck cancer, and possibly nonmelanoma skin cancer. However, they also suggest that patients with GW may differ from the general population with respect to important risk factors other than HPV, since excess risks of smoking-related cancers, for example, were observed. This study is important to clinicians in relation to the identification of cancers at an early stage, since it focuses attention to the longterm (≥10 years) risk of cancer in this patient group. In addition, the results may direct future studies of HPV DNA detection toward different types of tumors and may be valuable when estimating health benefits of HPV vaccination.
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